Pfizer to Buy Global Blood Therapeutics in $5.4 Billion Deal
Pfizer Inc. has agreed to pay $5.4 billion for Global Blood Therapeutics Inc., the manufacturer of a sickle-cell disease medication. …
Pfizer to Buy Global Blood Therapeutics in $5.4 Billion Deal Read More »
August 9, 2022 October 3, 2022